Oncology Care Center

What Oncology Care Center does

UPMC Hillman Cancer Center is an NCI-designated Comprehensive Cancer Center operating as part of the UPMC (University of Pittsburgh Medical Center) nonprofit healthcare system, headquartered in Pittsburgh, Pennsylvania. Founded in 1990, it operates 70+ clinical locations across Pennsylvania, Ohio, Maryland, and western New York, with a workforce of 2,000+ including 200+ medical, radiation, and surgical oncologists. It is one of only 57 NCI-designated Comprehensive Cancer Centers in the U.S. and the only one in western Pennsylvania, with 30+ years of continuous designation.

The center's treatment portfolio spans chemotherapy, immunotherapy (including the full range of FDA-approved CAR T-cell therapies), radiation oncology (Trilogy, TrueBeam STx, Gamma Knife), stem cell transplantation (autologous and allogeneic, 30+ years of experience), and targeted therapy. It operates specialized centers including the Mario Lemieux Center for Blood Cancers, Myeloma Specialty Care Center, Cancer Immunotherapeutics Center, and the Cancer Genetics Program. Diagnostic capability includes PET-CT imaging, a technology UPMC helped pioneer in 1998 (10,000+ clinical cases since), now extended via mobile units to community partners. The center also runs approximately 400-500 active clinical trials and holds accreditations from the American College of Radiology and The Joint Commission.

Revenue is generated primarily through patient care services across the network, supported by clinical trial funding (likely NCI grants and industry-sponsored trials). The center accepts major insurers including Highmark, Aetna, Cigna, United Healthcare, UPMC Health Plan, and government plans. Patient access is driven by physician referrals, self-referrals, and partnerships with regional health systems (Heritage Valley Health System, Washington Health System, Uniontown Hospital). No pricing is publicly disclosed. UPMC Hillman is a component of UPMC, a large nonprofit health system, and is not publicly traded.

Name

Oncology Care Center

Legal name

UPMC Hillman Cancer Center

Website

https://upmccancercenter.com

Company type

Private

Founded year

1990

Operating status

Operating

Headcount range

1–10 employees

Short description

UPMC Hillman Cancer Center is an NCI-designated Comprehensive Cancer Center within the UPMC health system, operating 70+ locations across four states with 2,000+ staff. It delivers comprehensive adult oncology care including CAR T-cell therapy, stem cell transplant, radiation oncology, and clinical trials, serving patients across Pennsylvania, Ohio, Maryland, and western New York.

Ownership category

akta.pro rank

Product category

Oncology Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Ambulatory Health Care Services (621), Offices of Physicians (62111)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM), Medical Oncology (HLAKAFAB), Radiation Oncology (HLAKAFAC)

Keywords

• Cancer treatment services
• Radiation oncology
• Medical oncology
• Clinical trials
• Immunotherapy services

Headquarters

HQ city

Belleville, Illinois

HQ country

United States

HQ region

North America

Offices16 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Patient Care Services: Revenue generated from comprehensive cancer treatment services including chemotherapy, immunotherapy, radiation therapy, surgery, stem cell transplants, and CAR T-cell therapy across 70+ locations.
2. Clinical Trials: Research and clinical trial programs generating revenue through NCI grants and potentially trial participation fees.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Oncology Care Center operates a comprehensive cancer care network delivering diagnosis, treatment, and survivorship services for adult cancer patients. Services span medical oncology (chemotherapy, immunotherapy, hormone therapy, targeted therapy), radiation oncology (including Trilogy, TrueBeam STx, Gamma Knife, and stereotactic radiosurgery), surgical oncology, stem cell transplantation, CAR T-cell therapy, and advanced diagnostic imaging such as PET-CT. Patients gain access to approximately 400–500 clinical trials and a multidisciplinary care model delivered across 70+ locations.

Product overview

UPMC Hillman Cancer Center is a comprehensive cancer care network offering a unified portfolio of cancer treatment services. The center provides specialized treatment through dedicated centers including the Mario Lemieux Center for Blood Cancers, Myeloma Specialty Care Center, and Cancer Immunotherapeutics Center. Core treatment services include chemotherapy, immunotherapy (including CAR T-cell therapy), radiation oncology, and stem cell transplantation. Advanced diagnostic capabilities include PET-CT scans and various imaging technologies. The center also offers access to approximately 400-500 clinical trials. With over 70 locations and 200+ medical, radiation, and surgical oncologists, the network delivers coordinated cancer care from diagnosis through treatment and survivorship support.

Differentiator

Problem solved

Functional benefit

Brands

• Mario Lemieux Center for Blood Cancers: Specialized center offering personalized treatments for patients with all types of blood cancer, including CAR T-cell therapy and stem cell transplant.
• Cancer Immunotherapeutics Center
• Koch Regional Cancer Therapy Center
• Gumberg Family Resource Center

Products and services

• Mario Lemieux Center for Blood Cancers Specialized center offering personalized treatments for patients with all types of blood cancer, including leukemia, lymphoma, multiple myeloma, and related conditions, including CAR T-cell therapy and stem cell transplants.
• CAR T-Cell Therapy Chimeric antigen receptor (CAR) T-cell therapy that uses a person's own T cells to find and kill cancer cells. UPMC Hillman Cancer Center was one of the first centers in the U.S. to offer CAR T-cell immunotherapy and offers the full range of FDA-approved CAR T-cell therapies.
• Stem Cell Transplant Hematopoietic stem cell transplantation that replaces damaged blood-forming stem cells with healthy stem cells. Includes autologous and allogeneic transplant options; inpatient unit at UPMC Shadyside with 28 single-patient rooms with HEPA filtration.
• Chemotherapy Powerful drugs used to kill fast-growing cancer cells in the body, traveling through the bloodstream to reach cancer cells throughout the body.
• Immunotherapy Biotherapy that uses the body's immune system to stop, slow the growth of, or kill cancer cells. Includes checkpoint inhibitors, cytokines, and monoclonal antibodies.
• PET-CT Scans Advanced diagnostic imaging combining positron emission tomography (PET) and computed tomography (CT) to precisely locate tumors and assess cancer spread.
• Radiation Oncology High-energy x-ray treatment to destroy cancer cells or prevent them from growing and dividing, including external beam radiation therapy and stereotactic radiosurgery.
• Trilogy Radiosurgery System Advanced linear accelerator and radiosurgery system with image-guided technology for precise tumor targeting. Treats tumors in hard-to-reach places with motion tracking during breathing.
• Myeloma Specialty Care Center Specialized center for plasma cell disorders offering streamlined care with latest treatment options and clinical trials for multiple myeloma and related conditions.
• Clinical Trials Access to nearly 400-500 clinical trials offering patients the latest advances in cancer prevention, detection, diagnosis, and treatment.

Named customers7 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Three partnerships are on record, tiered core.

• Heritage Valley Health SystemcoreStrategic or Co-development PartnerPartnership for PET-CT scan locations at Ellwood City and Chippewa, PA. Provides diagnostic imaging services to patients in the Beaver Falls area without requiring travel to larger facilities.
• Washington Health SystemcoreStrategic or Co-development PartnerPartnership for radiation oncology and PET-CT scanning at Washington, PA location. Extends advanced cancer diagnostic and treatment services to southwestern Pennsylvania communities.
• Uniontown HospitalcoreStrategic or Co-development PartnerPartnership for radiation oncology at Uniontown Hospital providing PET-CT scanning services to Fayette County residents closer to home.

Scale indicators11 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Dana-Farber Cancer Institute: Boston-based NCI-designated Comprehensive Cancer Center affiliated with Harvard. Comparable as a research-driven specialty cancer center with strong clinical trial portfolio, advanced cellular therapy program, and academic medical center partnership model similar to Hillman's University of Pittsburgh affiliation.
• Mayo Clinic Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center within the Mayo Clinic health system. Comparable as a specialty cancer program embedded in a large nonprofit health system with multi-site regional delivery, advanced treatment modalities, and significant research output.
• Fox Chase Cancer Center: Philadelphia-based NCI-designated Comprehensive Cancer Center. Comparable as a regional specialty oncology institution serving the mid-Atlantic with similar geographic proximity to Hillman's catchment area, creating direct competition for referrals and trials.
• Moffitt Cancer Center: Florida-based NCI-designated Comprehensive Cancer Center. Comparable as a specialty oncology hospital offering chemotherapy, radiation, immunotherapy, and stem cell transplantation with strong clinical trial enrollment and research focus.
• Memorial Sloan Kettering Cancer Center: New York-based NCI-designated Comprehensive Cancer Center offering chemotherapy, radiation, surgery, CAR T-cell therapy, and stem cell transplantation. Comparable as a specialty oncology institution with deep clinical trial portfolio and reputation for advanced therapies.
• Roswell Park Comprehensive Cancer Center: Buffalo, NY-based NCI-designated Comprehensive Cancer Center and the first U.S. cancer center (founded 1898). Comparable as a specialty hospital delivering multi-modality cancer treatment, cellular therapy, and clinical trials within a regional footprint overlapping Hillman's western NY territory.
• MD Anderson Cancer Center: One of the original NCI-designated Comprehensive Cancer Centers and the largest in the U.S., located in Houston, TX. Comparable as a flagship cancer specialty hospital network delivering multi-modality treatment, clinical trials, and research across all adult cancer types.
• Fred Hutchinson Cancer Center: Seattle-based NCI-designated Comprehensive Cancer Center, historically a leader in stem cell transplantation and immunotherapy. Comparable as a specialty cancer research institution with strong cellular therapy program and clinical trial portfolio.
• Johns Hopkins Sidney Kimmel Cancer Center: Baltimore-based NCI-designated Comprehensive Cancer Center embedded within Johns Hopkins Medicine. Comparable as an academic specialty cancer program offering cellular therapies, stem cell transplantation, and clinical trials within a major health system.

Broad incumbents

• UPMC (University of Pittsburgh Medical Center): The parent nonprofit health system of UPMC Hillman Cancer Center. Comparable as the broader healthcare delivery organization that provides hospital infrastructure, capital allocation, and operational scale underpinning Hillman's specialty cancer operations.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/oncology-care-center

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Oncology Care Center